Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Beta-blockers for hypertension: Are they going out of style?
Cleveland Clinic Journal of Medicine, 09/03/09
Che QI et al. – Although beta–blockers lower blood pressure in most patients, the outcomes of clinical hypertension trials of these drugs have been disappointing, and the value of beta–blockers in treating hypertensive patients who do not have compelling indications for them has been questioned. Until these drugs are proved beneficial, they should be used as antihypertensive therapy only in patients with compelling cardiac indications for them or as add–on agents in those with uncontrolled or resistant hypertension.
- No evidence exists that beta–blockers prevent first episodes of cardiovascular events in patients with hypertension, and in some trials, outcomes were worse with beta–blockers than with antihypertensive drugs of other classes.
- Younger hypertensive patients have hemodynamic characteristics that would seem to be amenable to beta–blocker therapy. However, most clinical trials of beta blockers did not stratify patients by age.
- Most trials of the antihypertensive effects of beta–blockers used atenolol (Tenormin), which is not an ideal representative of this class of drugs.
- Newer beta–blockers with vasodilatory properties may overcome the adverse effect of increased peripheral vascular resistance that occurs with older agents such as atenolol.
Related Articles
Preventing Heart Attacks During Surgery: Drugs Not Foolproof
Ivanhoe, 11/06/09
Relevance Score: 85%
Perioperative Use of beta-Blockers in the Elderly Patient
Anesthesiology Clinics, 10/15/09
Relevance Score: 84%
Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition
Clinical and Experimental Dermatology, 10/30/09
Relevance Score: 80%
Use and cost of branded and generic drugs in patients with coronary heart disease-results from a prospective survey of 1008 patients in two London hospitals
QJM: An International Journal of Medicine, 10/16/09
Relevance Score: 80%
Respiratory Effects of beta-blocker Therapy in Heart Failure
Cardiovascular Drugs and Therapy, 10/06/09
Relevance Score: 80%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
New England Journal of Medicine, 12/17/09
Relation of 12-Lead Electrocardiogram Patterns to Implanted Defibrillator-Terminated Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy
The American Journal of Cardiology, 12/17/09
Histopathology of Clinical Coronary Restenosis in Drug-Eluting Versus Bare Metal Stents
The American Journal of Cardiology, 12/17/09
Today in Internal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Grading and Reporting Health and Health Disparities
Preventing Chronic Disease, 12/17/09
Omega-3 fatty acids and cognitive function in women
Women's Health, 12/17/09
Handling cues from patients
Canadian Family Physician, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


